{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:42:26Z","timestamp":1790106146042,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"crossref","award":["754"],"award-info":[{"award-number":["754"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.molimm.2017.09.010","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T23:31:41Z","timestamp":1506814301000},"page":"202-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7\/8 in a vaccine against leishmaniasis in BALB\/c mice"],"prefix":"10.1016","volume":"91","author":[{"given":"Mosayeb","family":"Rostamian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid M.","family":"Niknam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"50","key":"10.1016\/j.molimm.2017.09.010_bib0005","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1016\/j.vaccine.2009.09.066","article-title":"Optimized subunit vaccine protects against experimental leishmaniasis","volume":"27","author":"Bertholet","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2017.09.010_bib0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1749-6632.1993.tb35934.x","article-title":"Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10","volume":"685","author":"Bogdan","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.molimm.2017.09.010_bib0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/SHK.0000000000000042","article-title":"The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants","volume":"40","author":"Bohannon","year":"2013","journal-title":"Shock"},{"issue":"32","key":"10.1016\/j.molimm.2017.09.010_bib0020","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1016\/j.vaccine.2005.03.019","article-title":"Safety and immunogenicty of RTS,S\/AS02A candidate malaria vaccine in Gambian children","volume":"23","author":"Bojang","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.molimm.2017.09.010_bib0025","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1590\/S0100-879X2005000700001","article-title":"What about Th1\/Th2 in cutaneous leishmaniasis vaccine discovery?","volume":"38","author":"Campos-Neto","year":"2005","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"10.1016\/j.molimm.2017.09.010_bib0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jmii.2014.01.006","article-title":"Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB\/c mice against Leishmania (Leishmania) amazonensis infection","volume":"49","author":"Cargnelutti","year":"2016","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.molimm.2017.09.010_bib0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4419-1603-7_10","article-title":"Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results","volume":"667","author":"Cluff","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.molimm.2017.09.010_bib0040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends Parasitol."},{"issue":"3","key":"10.1016\/j.molimm.2017.09.010_bib0045","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.exppara.2011.07.001","article-title":"Immunogenicity of Leishmania donovani iron superoxide dismutase B1 and peroxidoxin 4 in BALB\/c mice: the contribution of toll-like receptor agonists as adjuvant","volume":"129","author":"Daifalla","year":"2011","journal-title":"Exp. Parasitol."},{"issue":"2","key":"10.1016\/j.molimm.2017.09.010_bib0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine adjuvants: from 1920 to 2015 and beyond","volume":"3","author":"Di Pasquale","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.molimm.2017.09.010_bib0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.exppara.2016.05.005","article-title":"Innate immunomodulation to trypanosomatid parasite infections","volume":"167","author":"Dos-Santos","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.molimm.2017.09.010_bib0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.actatropica.2016.04.004","article-title":"Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB\/c mice-based experimental setting","volume":"159","author":"Fakhraee","year":"2016","journal-title":"Acta Trop."},{"issue":"3","key":"10.1016\/j.molimm.2017.09.010_bib0065","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.actatropica.2013.07.021","article-title":"Induction of protection against leishmaniasis in susceptible BALB\/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA)","volume":"128","author":"Firouzmand","year":"2013","journal-title":"Acta Trop."},{"issue":"10","key":"10.1016\/j.molimm.2017.09.010_bib0070","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.4049\/jimmunol.177.10.6584","article-title":"Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides","volume":"177","author":"Gorden","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2017.09.010_bib0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.actatropica.2011.04.007","article-title":"Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB\/c mice","volume":"119","author":"Kaur","year":"2011","journal-title":"Acta Trop."},{"issue":"22","key":"10.1016\/j.molimm.2017.09.010_bib0080","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/j.vaccine.2012.03.004","article-title":"Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice","volume":"30","author":"Lumsden","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2017.09.010_bib0085","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0405s55","article-title":"Delayed-type hypersensitivity","author":"Luo","year":"2001","journal-title":"Curr. Protoc. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2017.09.010_bib0090","first-page":"41","article-title":"The problem of mixing up of leishmania isolates in the laboratory: suggestion of ITS1 gene sequencing for verification of species","volume":"6","author":"Mahmoudzadeh-Niknam","year":"2011","journal-title":"Iran J. Parasitol."},{"issue":"2","key":"10.1016\/j.molimm.2017.09.010_bib0095","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.exppara.2010.10.008","article-title":"Protective immunity against Leishmania major induced by Leishmania tropica infection of BALB\/c mice","volume":"127","author":"Mahmoudzadeh-Niknam","year":"2011","journal-title":"Exp. Parasitol."},{"issue":"2","key":"10.1016\/j.molimm.2017.09.010_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148984","article-title":"TLR4 and TLR7\/8 adjuvant combinations generate different vaccine antigen-Specific immune outcomes in minipigs when administered via the ID or IN routes","volume":"11","author":"McKay","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2017.09.010_bib0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13071-016-1777-x","article-title":"Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery","volume":"9","author":"Mendonca","year":"2016","journal-title":"Parasit Vectors"},{"issue":"23","key":"10.1016\/j.molimm.2017.09.010_bib0110","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.vaccine.2010.01.015","article-title":"Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis","volume":"28","author":"Nagill","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.molimm.2017.09.010_bib0115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nri2097","article-title":"T(H)1 cells control themselves by producing interleukin-10","volume":"7","author":"O'Garra","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2017.09.010_bib0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1749-6632.2012.06786.x","article-title":"Regulation of toll-like receptor signaling pathways in innate immune responses","volume":"1283","author":"Qian","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molimm.2017.09.010_bib0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2180-10-181","article-title":"Comparison of BCG MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis","volume":"10","author":"Ravindran","year":"2010","journal-title":"BMC Microbiol."},{"issue":"5\u20136","key":"10.1016\/j.molimm.2017.09.010_bib0130","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.micinf.2005.03.011","article-title":"Tuberculosis vaccine development; from mouse to man","volume":"7","author":"Reed","year":"2005","journal-title":"Microbes Infect."},{"issue":"11","key":"10.1016\/j.molimm.2017.09.010_bib0135","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1128\/IAI.73.11.7620-7628.2005","article-title":"Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection","volume":"73","author":"Roberts","year":"2005","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.molimm.2017.09.010_bib0140","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4049\/jimmunol.0901114","article-title":"Regulatory B cells shape the development of Th2 immune responses in BALB\/c mice infected with Leishmania major through IL-10 production","volume":"184","author":"Ronet","year":"2010","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2017.09.010_bib0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jmii.2015.05.007","article-title":"Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB\/c mice","volume":"50","author":"Rostamian","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.molimm.2017.09.010_bib0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.0105-2896.2004.00185.x","article-title":"Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice","volume":"201","author":"Sacks","year":"2004","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.molimm.2017.09.010_bib0155","first-page":"11","article-title":"Animal models for the analysis of immune responses to leishmaniasis","volume":"19","author":"Sacks","year":"2015","journal-title":"Curr. Protoc. Immunol. 108"},{"issue":"11","key":"10.1016\/j.molimm.2017.09.010_bib0160","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2017.09.010_bib0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.139.1.221","article-title":"Vaccination against cutaneous leishmaniasis in a murine model. I: induction of protective immunity with a soluble extract of promastigotes","volume":"139","author":"Scott","year":"1987","journal-title":"J. Immunol."},{"issue":"26","key":"10.1016\/j.molimm.2017.09.010_bib0170","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1016\/j.vaccine.2012.03.040","article-title":"Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis","volume":"30","author":"Shargh","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.molimm.2017.09.010_bib0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/expr.2001.4656","article-title":"A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation","volume":"99","author":"Spath","year":"2001","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.molimm.2017.09.010_bib0180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","article-title":"Possibilities and challenges for developing a successful vaccine for leishmaniasis","volume":"9","author":"Srivastava","year":"2016","journal-title":"Parasit Vectors"},{"issue":"8","key":"10.1016\/j.molimm.2017.09.010_bib0185","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/IAI.67.8.3719-3726.1999","article-title":"Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major","volume":"67","author":"Stacey","year":"1999","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.molimm.2017.09.010_bib0190","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.parint.2014.10.003","article-title":"Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis","volume":"64","author":"Thakur","year":"2015","journal-title":"Parasitol. Int."},{"issue":"5","key":"10.1016\/j.molimm.2017.09.010_bib0195","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1586\/14760584.6.5.835","article-title":"Resiquimod and other immune response modifiers as vaccine adjuvants","volume":"6","author":"Tomai","year":"2007","journal-title":"Expert Rev. Vaccines"},{"issue":"7","key":"10.1016\/j.molimm.2017.09.010_bib0200","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1586\/14760584.2013.811208","article-title":"The use of toll-like receptor 7\/8 agonists as vaccine adjuvants","volume":"12","author":"Vasilakos","year":"2013","journal-title":"Expert Rev. Vaccines"},{"issue":"45","key":"10.1016\/j.molimm.2017.09.010_bib0205","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1016\/j.vaccine.2005.06.024","article-title":"TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)","volume":"23","author":"Weeratna","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.molimm.2017.09.010_bib0210","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12639-014-0521-8","article-title":"Immune responses in DNA vaccine formulated with PMMA following immunization and after challenge with Leishmania major","volume":"40","author":"Zarrati","year":"2016","journal-title":"J. Parasit. Dis."},{"issue":"8","key":"10.1016\/j.molimm.2017.09.010_bib0215","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/IAI.01527-07","article-title":"Immunization with a Toll-like receptor 7 and\/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB\/c mice","volume":"76","author":"Zhang","year":"2008","journal-title":"Infect. Immun."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589017305096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589017305096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T16:58:07Z","timestamp":1693069087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589017305096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":43,"alternative-id":["S0161589017305096"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2017.09.010","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7\/8 in a vaccine against leishmaniasis in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2017.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}